Importance: Fundus aging and its imaging features.
INTRODUCTION
Age-related scattered hypofluorescent spots on late-phase indocyanine green angiography (ASHS-LIA) were first reported by Shiraki et al. in 1999. 1 Their study, with a relatively small sample size including eyes with both a normal fundus and dry age-related maculopathy, demonstrated that ASHS-LIA was age-related but not correlated with dry age-related maculopathy. ASHS-LIA was distributed in the posterior pole, especially in the macular region. The hypofluorescent spots were noted on latephase indocyanine green angiography (ICGA), and it was different from the hypofluorescent lesions common in patients with inflammatory conditions involving the choroid such as multifocal choroiditis and acute posterior multifocal placoid pigment epitheliopathy (APMPPE). 2, 3 However, there was no article further describing this finding, and the multimodal imaging features of ASHS-LIA, including autofluorescence (AF) and optical coherence tomography (OCT) were not described before. So far, what ASHS-LIA really represents is still not clear.
ICGA is mainly used in the diagnosis of fundus diseases, especially choroidal diseases. As we know, indocyanine green (ICG) dye is water-soluble and may bind to lipid due to polarity but does not bind to hydrophobic neutral lipids. Research showed that ICG dye was located within retinal and choroidal vessels in the early-phase after injection; however, it was extravasated into the choroidal stroma and accumulated within the retinal pigment epithelium (RPE) over time. 4, 5 Therefore, fundus fluorescence characteristics on late-phase ICGA might be very important to indicate the pathogenesis of the fundus disease. In addition, the multimodal imaging including colour fundus photography (FP), fundus fluorescein angiography (FFA), AF and OCT might contribute to analyse what ASHS-LIA really represents.
The purpose of the present study was to characterize the demographic and multimodal imaging features of ASHS-LIA and to explore its possible underlying relevant factors.
METHODS
This is a retrospective, cross-sectional study. All patients who were referred to the Zhongshan Ophthalmic Center for ICGA, FFA, colour FP, AF and OCT examination between January 2014 and April 2017 were reviewed. Patients who had a previous ophthalmological intervention procedure, such as laser coagulation, vitrectomy, anti-vascular endothelial growth factor injection or photodynamic dynamic therapy in one or both eyes, were excluded from this study. Furthermore, patients with poorquality images affecting fluorescence judgement, or patients with bilateral lesions were excluded. In addition, patients with inflammatory conditions involving the choroid such as multifocal choroiditis and APMPPE were also excluded. After these criteria were applied, 875 normal fundi fellow eyes from 875 patients were eligible for inclusion in this study. It must be paid for attention that 'normal fundi fellow eyes' in this study were defined as no definite fundus diseases, such as retinal vascular diseases, choroidal neovascular diseases, RPE-related diseases or hereditary fundus diseases, and so on.
The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Zhongshan Ophthalmic Center at Sun Yat-sen University. Potential risks associated with ICGA and FFA examination were fully discussed with the patients, and written informed consent was obtained from all included patients.
Demographic information, medical records and multimodal imaging data were reviewed. The bestcorrected visual acuity (BCVA) was measured with Snellen charts; Colour FP was performed with a Zeiss FF450 Plus fundus camera (Carl Zeiss, Inc., Jena, Germany). ICGA, FFA and AF were performed with Heidelberg Retina Angiogram (Spectralis HRA, Heidelberg Engineering, Heidelberg, Germany). OCT was performed with an HRA + OCT Spectralis (Heidelberg Engineering, Heidelberg, Germany). Two ophthalmologists (Ling Chen and Xiongze Zhang) independently assessed and diagnosed the patients, assessed whether there was ASHS-LIA, and characterized its ICGA and multimodal imaging features, if ASHS-LIA exists. In addition, the subfoveal choroidal thickness (SFCT) was detected by enhanced depth imaging OCT (EDI-OCT) as previous method. 6 When the two ophthalmologists disagreed, the final decision was made by consulting a retinal specialist (Feng Wen).
Statistical analyses were performed with SPSS Version 21.0 software (SPSS, Inc., Chicago, IL, USA). Descriptive statistics (means AE standard deviations [SDs]) of normally distributed variables and geometric means with 95% confidence intervals (CIs) of non-normally distributed variables were calculated. Comparisons were evaluated by independent sample T-test or one-way analysis of variance (ANOVA) (normal data), or X 2 test (nonnormal data). Multiple logistic regression models were constructed to assess the independent relevant factors for ASHS-LIA. Odds ratios (ORs) and 95% CIs are shown. Significant differences were defined for P-values <0.05.
RESULTS

Patients
A total of 875 eyes from 875 patients were included in this study. The ages ranged from 6 to 90 years (mean: 54.2 AE 16.4 years), and the male: female ratio was 1.6:1. Among the 875 patients, ASHS-LIA was detected in 233 patients (26.6%). The ages of these patients ranged from 33 to 87 years (mean: 65.8 AE 8.4 years), and the male:female ratio was 2.6:1. Table 1 shows the demographic characteristics of patients with and without ASHS-LIA. A total of 233 patients were determined with ASHS-LIA, and the average age was 65.8 AE 8.4 years, which was significantly older than those without ASHS-LIA (mean: 50.0 AE 16.5 years) (t = −13.957, P < 0.001). The male proportion in patients with ASHS-LIA was 2.6:1, significantly higher than in patients without ASHS-LIA (1.4:1) (X 2 = 14.204, P < 0.001). Moreover, to explore the relationship between age and ASHS-LIA, patients were divided into five groups according to age (≤ 30, 31-45, 46-60, 61-75 and ≥ 76 years), and the incidence of ASHS-LIA in the different age groups was calculated as 0% (0/100), 1.4% (2/144), 20.4% (55/269), 47.8% (142/297) and 52.3% (34/65), respectively. Patients aged 61-75 years and patients older than 75 years had significantly higher occurrence rates of ASHS-LIA compared with other age groups (X 2 test, all P < 0.001); nevertheless, there was no significant difference between the 61-75 year age group and the greater-than-75 age group (X 2 = 0.432, P = 0.511). In addition, patients aged 46-60 years had significantly higher occurrence rates of ASHS-LIA compared with patients aged 31-45 years and patients younger than 30 years (X 2 test, both P < 0.001).
Among the total of 875 included patients, ASHS-LIA was observed in 53.2% (175/329) of PCV patients, 26.5% (22/83) of nAMD patients, 20% (7/35) of dry AMD patients, 6.5% (10/153) of CSC patients, 0% (0/41) of patients with normal fundi and 8.1% (19/234) of patients with other fundus diseases (including pathological myopia, idiopathic choroidal neovascularization, retinal macroaneurysms, central retinal vein occlusion, branch retinal vein occlusion, epiretinal membrane, idiopathic pigmentary epithelial detachment, focalchoroidal atrophy, choroidal hemangioma, choroidal melanoma, choroidal osteoma, coats' disease, optic neuropathy and syphilitic retinitis). Table 2 showed the incidence of ASHS-LIA and demographic characteristics by different diagnosis. Furthermore, the incidence of ASHS-LIA in PCV patients was the highest, significantly higher than that in patients with nAMD, dry AMD, CSC and normal fundi (X 2 test, all P < 0.001).
ICGA characteristics of ASHS-LIA
In our study, ASHS-LIA was observed as early as 15 min after ICG dye injection and was obvious by 30 min post-injection (Fig. 1) . ASHS-LIA mainly located in the macular region, even the whole posterior pole. When the whole posterior pole was involved, ASHS-LIA occasionally spread to the nasal near mid-periphery retina, but no spots were observed in the temporal near mid-periphery or the far mid-periphery retina in our study. The diameter of ASHS-LIA ranged from 100 to 500 μm, with the majority between 200 and 300 μm. Moreover, ASHS-LIA could be confluent, initially appearing in the macular region. According to the region of involvement, we divided ASHS-LIA into three grades ( Fig. 2a-c) , as follows: grade 1, macular region (68 out of 233), grade 2, macular region and around the optic disc (140 out of 233), and grade 3, throughout the posterior pole (25 out of 233). Confluent ASHS-LIA can occur at all levels ( Fig. 2d-f ). In addition, our study indicated that the mean age of patients was significantly correlated with the grade of ASHS-LIA (one-way ANOVA, all P < 0.001). Nevertheless, there was no significant correlation between the grade of ASHS-LIA and the sex of the patient (Table 3) .
Multimodal imaging features of ASHS-LIA
Among the 233 patients with ASHS-LIA, all patients underwent dilated colour FP, AF, FFA and OCT. No corresponding changes were observed via colour FP, AF, FFA and OCT in all cases. In brief, colour FP showed an almost normal fundus, and 1) † Data represent the means AE SD, n/T or %. ASHS-LIA, age-related scattered hypofluorescent spots on late-phase indocyanine green angiography; CSC, central serous chorioretinopathy; n, the number of patients with ASHS-LIA; nAMD, neovascular age-related macular degeneration; PCV, polypoidal choroidal vasculopathy; T, the total number of patients.
there was no abnormal fluorescence corresponding to ASHS-LIA on AF. Apart from faint uneven hypofluorescent spots were observed on very early stage of FFA in some patients, most patients showed uniform background fluorescence from early stage to late stage after fluorescein injection, with no abnormal fluorescence spots corresponding to ASHS-LIA. Additionally, OCT showed that retinal structures were generally normal and that the RPE band was intact and smooth, with no intraretinal, subretinal or 
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sub-RPE deposition corresponding to ASHS-LIA (Figs 3 and 4) . In addition, the mean SFCT had no significant difference between eyes with ASHS-LIA (295.1 AE 82.3) and without ASHS-LIA (286.9 AE 88.8) (t = 1.225, P = 0.221).
Independent relevant factors of ASHS-LIA
To determine the independent relevant factors of ASHS-LIA, multiple logistic regression models were constructed. Factors including age (continuous variable) and gender (two categorical variables) were included in the multiple logistic regression analysis.
The odds ratio (OR) for ASHS-LIA was 1.093 per year of age (95% CI = 1.076-1.111) (P < 0.001), and the β value was 0.089. In addition, compared to female patients, male patients had an increased occurrence of ASHS-LIA, by approximately 1.799-fold (OR = 1.799; 95% CI = 1.248-2.591) (P = 0.002), and the β value was 0.587 (Table 4) .
DISCUSSION
In the present study, we characterized the demographic and multimodal-imaging features of ASHS-LIA and analysed its possible related factors based Data represent n, means AE SD or %. ASHS-LIA, age-related scattered hypofluorescent spots on late-phase indocyanine green angiography; grade 1, ASHS-LIA in the macular region; grade 2, ASHS-LIA in the macular region and around the optic disc; grade 3, ASHS-LIA throughout the posterior pole. on clinical data from 875 consecutive patients received ICGA, FFA, AF, colour FP and OCT examination in our ophthalmic centre.
Our study showed that the average age of patients with ASHS-LIA was significantly higher than those without ASHS-LIA. Age stratification analysis also indicated that the occurrence of ASHS-LIA was positively correlated with old age. Multiple logistic regression analysis demonstrated that age was an independent relevant factor of ASHS-LIA. These findings indicated that age was a very important relevant factor for ASHS-LIA, so we speculated that ASHS-LIA might represent the aging of the fundus. Shiraki et al. reported that ASHS-LIA was observed in patients ranging in age from 51 to 80 years, 1 but in our study, patients with ASHS-LIA ranged in age from 33 to 87 years. This might be due to the fact that we included a larger number of patients and therefore a more comprehensive sample. In addition, the proportion of male in patients with ASHS-LIA was significantly higher than the proportion in patients without ASHS-LIA. And multiple logistic regression analysis demonstrated that male gender was an independent relevant factor of ASHS-LIA. Nevertheless, it is still unclear how male gender affects the occurrence of ASHS-LIA. We speculated that it might be associated with a marked male preponderance in common fundus diseases such as age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV) and central serous chorioretinopathy (CSC), [7] [8] [9] considering that we included normal fundi fellow eyes of patients with common fundus diseases.
Our study indicated that ASHS-LIA could be observed only by ICGA, and was obvious by 30 min post-injection of dye. It has been demonstrated in rats, primates and humans that ICG dye is located within retinal and choroidal vessels in the early-phase after injection; however, it is extravasated into the choroidal stroma and accumulated within the RPE over time. 4, 5 Therefore, under normal conditions, homogeneous background fluorescence was observed in late-phase ICGA. A lot of previous studies demonstrated that more neutral lipid accumulated in Bruch's membrane (BrM) with aging, increasing its hydrophobicity and decreasing its diffusional capacity. [10] [11] [12] [13] [14] [15] As we know, ICG is water-soluble and does not bind to hydrophobic neutral lipids, which may explain the ICGA characteristics and age-association of ASHS-LIA and indicate that ASHS-LIA may represent neutral lipid accumulating in BrM. In addition, ASHS-LIA mainly located in the macular region, and the grade of ASHS-LIA increased with age. That was in accordance with the distribution and progression of neutral lipid accumulating in the retina. 16 Nevertheless, why ASHS-LIA was arranged in such a regular pattern and look similar among subjects, rather than irregularly shaped lesions or streaks, was still unclear. We speculated that it might be partly explained by the hydrophobicity and surface tension of neutral lipids. 17 Then, if ASHS-LIA does represent neutral lipid accumulating in the retina, why no sub-RPE deposition was observed on OCT? As we know, BrM is the innermost 2-4 μm of the choroid (subjacent to the RPE), consisting of five layers of connective tissue. 18 Lipoproteins begin to accumulate by the fourth decade of life, and gradually form the 'lipid wall' (a thin tightly packed layer of 0.4-2 μm) between the inner collagenous layer of BrM and RPE basal lamina in many older eyes. [19] [20] [21] The minimum resolution of OCT is about 5 μm, therefore, the lipid wall cannot be showed by OCT. To explore the relevant factors of ASHS-LIA, the SFCT was detected, and our results showed that the mean SFCT had no significant difference between eyes with and without ASHS-LIA, which means that there might be no correlation between ASHS-LIA and SFCT changes.
In addition, the experiment in vitro demonstrated that cultured human RPE cells take up ICG dye, which might involve active transport. 22 Therefore, RPE cells dysfunction could result in the abnormality of ICG dye taking up, which might result in hypofluorescence on late-phase ICGA, and might be involved in the formation of ASHS-LIA. Additionally, although we evaluated the ASHS-LIA in normal fundi fellow eyes, our results showed that the incidence of ASHS-LIA was the highest in PCV patients. Therefore, we speculated that ASHS-LIA might be related to PCV, but we must consider the selection bias, for more PCV patients were included in this study.
There are several limitations to our study that need to be considered. Firstly, we evaluated the ASHS-LIA in normal fundi fellow eyes of patients in our study. These eyes may be regarded as clinically 'normal eyes', but they are not from 'normal subjects'. Secondly, this is a clinic-based retrospective study, selection bias may occur. The prevalence of PCV is relatively high in Chinese populations, so more PCV patients were included in this study. Thirdly, although we speculated that ASHS-LIA might represent neutral lipid accumulating in the retina, we have no direct pathological evidence and we cannot explain its regular arrangement pattern. However, considering difficulties in obtaining ICGA images in normal subjects, and the number of patients is large enough and it encompasses a large age range, therefore, our findings are comprehensive, reliable and meaningful.
In conclusion, ASHS-LIA was observed on latephase ICGA, and mainly located in macular region. No corresponding abnormalities were observed by other multimodal imaging modalities, including colour FP, FA, AF and OCT. The occurrence and grade of ASHS-LIA increased with age. Moreover, ASHS-LIA might be not correlated with SFCT, but correlated with PCV.
